Our paper “ A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapy” by Zhuan Zhou, Zhiwei Feng, Dong Hue, Peng Yang, Mert Gur, Ivet Bahar, Massimo Cristofanilli, William J. Gradishar, Xiang-qun Xied, and Yong Wan has been accepted for publication in EBioMedicine - The Lancet.